Armed oncolytic viruses: A kick-start for anti-tumor immunity by de Graaf, J.F., de Vor, L., Fouchier, R.A.M., van den Hoogen, B.G.

Get full text

Assessment of the virulence for chickens of Newcastle Disease virus with an engineered multi-basic cleavage site in the fusion protein and disrupted V protein gene by de Graaf, J.F., van Nieuwkoop, S., de Meulder, D., Lexmond, P., Kuiken, T., Groeneveld, D., Fouchier, R.A.M., van den Hoogen, B.G.

Get full text

Determinants of the efficacy of viro-immunotherapy: A review by de Graaf, J.F., Huberts, M., Fouchier, R.A.M., van den Hoogen, B.G.

Get full text

Personalization of oncolytic virus therapy: Heterogeneous anti-tumor responses in preclinical prostate and bladder cancer models by Janssen, T.J.A., Van Der Horst, G., Van De Merbel, A.F.M., Mark, M.M., Lamfers, M.F., Van Den Hoogen, B.G., Schalken, J.A., Hoeben, R.C., Van Der Pluijm, G.

Get full text

P01 - Personalization of oncolytic virus therapy: Heterogeneous anti-tumor responses in preclinical prostate and bladder cancer models by Janssen, T.J.A., Van Der Horst, G., Van De Merbel, A.F.M., Mark, M.M., Lamfers, M.F., Van Den Hoogen, B.G., Schalken, J.A., Hoeben, R.C., Van Der Pluijm, G.

Get full text

In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells by Berghauser Pont, L M E, Balvers, R K, Kloezeman, J J, Nowicki, M O, van den Bossche, W, Kremer, A, Wakimoto, H, van den Hoogen, B G, Leenstra, S, Dirven, C M F, Chiocca, E A, Lawler, S E, Lamfers, M L M

Get full text